Calidi Biotherapeutics (CLDI) Other Gross PP&E Adjustments (2022 - 2025)
Calidi Biotherapeutics' quarterly Other Gross PP&E Adjustments came in at -$1.5 million in Q4 2025, up 48.61% year-on-year from -$983772.5 in Q4 2024, and down 367.28% quarter-over-quarter from $547000.0 in Q3 2025.
Calidi Biotherapeutics has reported Other Gross PP&E Adjustments for 4 years, with the latest figure at -$1.5 million in Q4 2025.
- For the quarter ending Q4 2025, Other Gross PP&E Adjustments rose 48.61% year-over-year to -$1.5 million; the trailing twelve-month figure through Dec 2025 stood at -$1.5 million (up 48.61% YoY), and the FY2025 full-year result was -$1.5 million, up 48.61% from the prior year.
- Other Gross PP&E Adjustments for Q4 2025 stood at -$1.5 million, down from $547000.0 in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was $547000.0 in Q3 2025, with the low at -$5.6 million in Q4 2023.
- Average Other Gross PP&E Adjustments over 4 years is -$2.7 million, with a median of -$3.2 million recorded in 2024.
- Year-over-year, Other Gross PP&E Adjustments plunged 6655.84% in 2023 and jumped 115.16% in 2025.
- Tracing CLDI's Other Gross PP&E Adjustments over 4 years: stood at -$1.4 million in 2022, then slumped by 300.36% to -$5.6 million in 2023, then soared by 49.17% to -$2.8 million in 2024, then surged by 48.61% to -$1.5 million in 2025.
- The last three Other Gross PP&E Adjustments figures came in at -$1.5 million (Q4 2025), $547000.0 (Q3 2025), and $201000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,638,563.89 Bn | 1,638,563.89 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 767,934.24 Bn | 767,934.20 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,937.00 Bn | 2,936.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,282.79 Bn | 2,282.72 Bn | - | - |
| 5 | Akari Therapeutics | 2,169.69 Bn | 2,169.69 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.41 Bn | 103.16 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.44 Bn | 57.69 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.44 Bn | 65.42 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.53 Bn | 36.52 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Calidi Biotherapeutics | - | - | - | -1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.46 Mn |
| Dec 31, 2025 | -1.46 Mn |
| Sep 30, 2025 | 547,000.00 |
| Sep 30, 2025 | 547,000.00 |
| Jun 30, 2025 | 201,000.00 |
| Jun 30, 2025 | 201,000.00 |
| Mar 31, 2025 | -1.88 Mn |
| Mar 31, 2025 | -1.88 Mn |
| Dec 31, 2024 | -2.85 Mn |
| Dec 31, 2024 | -2.85 Mn |
| Sep 30, 2024 | -3.61 Mn |
| Sep 30, 2024 | -3.61 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Jun 30, 2024 | -3.98 Mn |
| Mar 31, 2024 | -4.36 Mn |
| Mar 31, 2024 | -4.36 Mn |
| Dec 31, 2023 | -5.60 Mn |
| Dec 31, 2023 | -5.60 Mn |
| Sep 30, 2023 | -5.05 Mn |
| Sep 30, 2023 | -5.05 Mn |
| Jun 30, 2023 | -4.15 Mn |
| Jun 30, 2023 | -4.15 Mn |
| Mar 31, 2023 | -4.40 Mn |
| Mar 31, 2023 | -4.40 Mn |
| Dec 31, 2022 | -1.40 Mn |
| Dec 31, 2022 | -1.40 Mn |
| Sep 30, 2022 | 77,000.00 |
| Sep 30, 2022 | 77,000.00 |